{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:38:30Z","timestamp":1794440310809,"version":"4.9.1"},"reference-count":122,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is a chronic inflammatory disease of the skin associated with systemic and joint manifestations and accompanied by comorbidities, such as metabolic syndrome and increased risk of cardiovascular disease. Psoriasis has a strong genetic basis, but exacerbation requires additional signals that are still largely unknown. The clinical manifestations involve the interplay between dendritic and T cells in the dermis to generate a self-sustaining inflammatory loop around the TNF\u03b1\/IL-23\/IL-17 axis that forms the psoriatic plaque. In addition, in recent years, a critical role of keratinocytes in establishing the interplay that leads to psoriatic plaques\u2019 formation has re-emerged. In this review, we analyze the most recent evidence of the role of keratinocytes and danger associates molecular patterns, such as extracellular ATP in the generation of psoriatic skin lesions. Particular attention will be given to purinergic signaling in inflammasome activation and in the initiation of psoriasis. In this phase, keratinocytes\u2019 inflammasome may trigger early inflammatory pathways involving IL-1\u03b2 production, to elicit the subsequent cascade of events that leads to dendritic and T cell activation. Since psoriasis is likely triggered by skin-damaging events and trauma, we can envisage that intracellular ATP, released by damaged cells, may play a role in triggering the inflammatory response underlying the pathogenesis of the disease by activating the inflammasome. Therefore, purinergic signaling in the skin could represent a new and early step of psoriasis; thus, opening the possibility to target single molecular actors of the purinome to develop new psoriasis treatments.<\/jats:p>","DOI":"10.3390\/ijms22179449","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T08:42:32Z","timestamp":1630399352000},"page":"9449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis"],"prefix":"10.3390","volume":"22","author":[{"given":"Davide","family":"Ferrari","sequence":"first","affiliation":[{"name":"Department of Life Science and Biotechnology, Section of Microbiology and Applied Pathology, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-3335","authenticated-orcid":false,"given":"Fabio","family":"Casciano","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy"},{"name":"Interdepartmental Research Center for the Study of Multiple Sclerosis and Inflammatory and Degenerative Diseases of the Nervous System, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Secchiero","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-1356","authenticated-orcid":false,"given":"Eva","family":"Reali","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fimmu.2019.00657","article-title":"Editorial: Immunology of Psoriatic Disease","volume":"10","author":"Reali","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of Chronic Plaque Psoriasis and Its Intersection with Cardio-Metabolic Comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/TH 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2018.01390","article-title":"T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities","volume":"9","author":"Casciano","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kim, J., Lee, J., Kim, H.J., Kameyama, N., Nazarian, R., Der, E., Cohen, S., Guttman-Yassky, E., Putterman, C., and Krueger, J.G. (2021). Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. J. Allergy Clin. Immunol.","DOI":"10.1016\/j.jaci.2021.04.021"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1523-1747.ep12335758","article-title":"T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice","volume":"109","author":"Gilhar","year":"1997","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clindermatol.2007.08.013","article-title":"Resident skin cells in psoriasis: A special look at the pathogenetic functions of keratinocytes","volume":"25","author":"Albanesi","year":"2007","journal-title":"Clin. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Madonna, S., Girolomoni, G., Dinarello, C.A., and Albanesi, C. (2019). The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133318"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mercurio, L., Failla, C.M., Capriotti, L., Scarponi, C., Facchiano, F., Morelli, M., Rossi, S., Pagnanelli, G., Albanesi, C., and Cavani, A. (2020). Interleukin (IL)-17\/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0222969"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Capon, F. (2017). The Genetic Basis of Psoriasis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122526"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Liu, Y., Helms, C., Liao, W., Zaba, L.C., Duan, S., Gardner, J., Wise, C., Miner, A., Malloy, M.J., and Pullinger, C.R. (2008). A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet., 4.","DOI":"10.1371\/journal.pgen.1000041"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jid.2019.11.027","article-title":"Molecular and Cellular Responses to the TYK2\/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis","volume":"140","author":"Page","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/jid.2011.14","article-title":"New psoriasis susceptibility genes: Momentum for skin-barrier disruption","volume":"131","author":"Coto","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61ra90","DOI":"10.1126\/scitranslmed.3001108","article-title":"Gene from a psoriasis susceptibility locus primes the skin for inflammation","volume":"2","author":"Wolf","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","article-title":"The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants","volume":"74","author":"Sugiura","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20160270","article-title":"Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-kappaB activation","volume":"473","author":"Howes","year":"2016","journal-title":"Biochem. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: A trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nature00820","article-title":"TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2","volume":"417","author":"Pasparakis","year":"2002","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/jid.2013.39","article-title":"Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation, and epidermal organelles","volume":"133","author":"Borkowski","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11427-016-0027-2","article-title":"TLR3 activation induces S100A7 to regulate keratinocyte differentiation after skin injury","volume":"60","author":"Lei","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jid.2018.12.019","article-title":"Mechanical Stretch Exacerbates Psoriasis by Stimulating Keratinocyte Proliferation and Cytokine Production","volume":"139","author":"Qiao","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.03.009","article-title":"Keratinocytes express functional CARD18, a negative regulator of inflammasome activation, and its altered expression in psoriasis may contribute to disease pathogenesis","volume":"73","author":"Goblos","year":"2016","journal-title":"Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: From Pathogenesis to Targeted Therapies","volume":"54","author":"Conrad","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","article-title":"Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon","volume":"9","author":"Mylonas","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Furue, M., Furue, K., Tsuji, G., and Nakahara, T. (2020). Interleukin-17A and Keratinocytes in Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041275"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2018.04.031","article-title":"Detection of IL-36gamma through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema","volume":"142","author":"Berekmeri","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/jid.2014.532","article-title":"IL-36gamma (IL-1F9) is a biomarker for psoriasis skin lesions","volume":"135","author":"Wagenpfeil","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: Keratinocytes or Immune Cells\u2014Which Is the Trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Akdis, C.A. (2021). Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?. Nat. Rev. Immunol.","DOI":"10.1038\/s41577-021-00538-7"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/jid.2014.205","article-title":"Abnormal epidermal barrier recovery in uninvolved skin supports the notion of an epidermal pathogenesis of psoriasis","volume":"134","author":"Ye","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Olejniczak-Staruch, I., Ciazynska, M., Sobolewska-Sztychny, D., Narbutt, J., Skibinska, M., and Lesiak, A. (2021). Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083998"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcimb.2019.00007","article-title":"Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris","volume":"9","author":"Visser","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jaci.2018.08.042","article-title":"Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1alpha release","volume":"143","author":"Archer","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Takahashi, T., and Yamasaki, K. (2020). Psoriasis and Antimicrobial Peptides. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186791"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.1992.01680110049004","article-title":"The role of streptococcal infection in the initiation of guttate psoriasis","volume":"128","author":"Telfer","year":"1992","journal-title":"Arch. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1365-2133.2003.05552.x","article-title":"Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study","volume":"149","author":"Gudjonsson","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.1987.tb05794.x","article-title":"HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions","volume":"116","author":"Terui","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"599947","DOI":"10.3389\/fimmu.2020.599947","article-title":"Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes","volume":"11","author":"Christmann","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic signaling, DAMPs, and inflammation","volume":"318","author":"Sarti","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tcb.2018.01.005","article-title":"The Elusive P2X7 Macropore","volume":"28","author":"Schmalzing","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jid.2016.07.028","article-title":"Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis","volume":"137","author":"Andres","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1084\/jem.21213insight3","article-title":"An autoimmune \u201cttack\u201d on melanocytes triggers psoriasis and cellular hyperplasia","volume":"212","author":"Krueger","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.it.2021.05.001","article-title":"NLRP3 inflammasomes that induce antitumor immunity","volume":"42","author":"Zhivaki","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11302-012-9338-z","article-title":"Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles","volume":"9","author":"Jayasekara","year":"2013","journal-title":"Purinergic Signal."},{"key":"ref_56","first-page":"527","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.drudis.2014.02.010","article-title":"Adenosine and inflammation: What\u2019s new on the horizon?","volume":"19","author":"Antonioli","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI0210649","article-title":"Elucidation of the thromboregulatory role of CD39\/ectoapyrase in the ischemic brain","volume":"109","author":"Pinsky","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.107.690180","article-title":"CD39\/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia\/reperfusion injury","volume":"116","author":"Kohler","year":"2007","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ecco-jcc\/jjz182","article-title":"Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn\u2019s Disease","volume":"14","author":"Robles","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jid.2011.344","article-title":"Purinergic signaling in healthy and diseased skin","volume":"132","author":"Burnstock","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s002100000310","article-title":"Molecular pharmacology of P2Y-receptors","volume":"362","author":"Wetter","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_63","first-page":"1","article-title":"UTP as an extracellular signaling molecule","volume":"16","author":"Lazarowski","year":"2001","journal-title":"News Physiol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00424-006-0069-2","article-title":"P2 receptors: Intracellular signaling","volume":"452","author":"Erb","year":"2006","journal-title":"Pflugers Arch."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2020.01179","article-title":"The P2X7 Receptor as Regulator of T Cell Development and Function","volume":"11","author":"Grassi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1161\/ATVBAHA.114.303585","article-title":"P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice","volume":"34","author":"Stachon","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.cub.2007.05.074","article-title":"The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes","volume":"17","author":"Feldmeyer","year":"2007","journal-title":"Curr. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdermsci.2014.09.002","article-title":"Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: Possible implications for rosacea","volume":"76","author":"Salzer","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fimmu.2020.00882","article-title":"Inflammasomes in Common Immune-Related Skin Diseases","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.12659\/MSM.911347","article-title":"Expression of NLPR3 in Psoriasis Is Associated with Enhancement of Interleukin-1beta and Caspase-1","volume":"24","author":"Su","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Ciazynska, M., Olejniczak-Staruch, I., Sobolewska-Sztychny, D., Narbutt, J., Skibinska, M., and Lesiak, A. (2021). The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115898"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/jid.2010.370","article-title":"Caspase-5 expression is upregulated in lesional psoriatic skin","volume":"131","author":"Johansen","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_76","first-page":"1086","article-title":"Silencing of miR155 suppresses inflammatory responses in psoriasis through inflammasome NLRP3 regulation","volume":"42","author":"Luo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/exd.12037","article-title":"Strong induction of AIM2 expression in human epidermis in acute and chronic inflammatory skin conditions","volume":"21","author":"Bergboer","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/1346-8138.14478","article-title":"Key component of inflammasome, NLRC4, was identified in the lesional epidermis of psoriatic patients","volume":"45","author":"Hiruma","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"105682","DOI":"10.1016\/j.intimp.2019.105682","article-title":"Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice","volume":"74","author":"Deng","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/bjd.13178","article-title":"Genetic variations of NLRP1: Susceptibility in psoriasis","volume":"171","author":"Ekman","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/exd.12049","article-title":"Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility","volume":"21","author":"Carlstrom","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/03009742.2020.1834611","article-title":"Association between inflammasome-related polymorphisms and psoriatic arthritis","volume":"50","author":"Juneblad","year":"2021","journal-title":"Scand. J. Rheumatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"22745","DOI":"10.1038\/srep22745","article-title":"NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis","volume":"6","author":"Tervaniemi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Fenini, G., Karakaya, T., Hennig, P., Di Filippo, M., and Beer, H.D. (2020). The NLRP1 Inflammasome in Human Skin and Beyond. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134788"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Gaire, B.P., Lee, C.H., Kim, W., Sapkota, A., Lee, D.Y., and Choi, J.W. (2020). Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages. Cells, 9.","DOI":"10.3390\/cells9081753"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fphar.2020.01238","article-title":"The Inflammasome Signaling Proteins ASC and IL-18 as Biomarkers of Psoriasis","volume":"11","author":"Forouzandeh","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.freeradbiomed.2019.11.031","article-title":"Redox regulation of cutaneous inflammasome by ozone exposure","volume":"152","author":"Ferrara","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","article-title":"Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation","volume":"141","author":"Verma","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.0906988106","article-title":"IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells","volume":"106","author":"Guo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.0022-202X.2004.22305.x","article-title":"Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist","volume":"122","author":"Shepherd","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1172\/JCI90699","article-title":"TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies","volume":"127","author":"McGeough","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jid.2020.08.034","article-title":"Killing Two Birds with One Stone: TNF Antagonists Downregulate Systemic IL-1beta in Psoriasis","volume":"141","author":"Contassot","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"82ra38","DOI":"10.1126\/scitranslmed.3002001","article-title":"Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions","volume":"3","author":"Dombrowski","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature24271","article-title":"Inflammatory memory sensitizes skin epithelial stem cells to tissue damage","volume":"550","author":"Naik","year":"2017","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fimmu.2019.01525","article-title":"The Role of Epigenetics in Autoimmune\/Inflammatory Disease","volume":"10","author":"Surace","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Taruno, A. (2018). ATP Release Channels. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030808"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"594097","DOI":"10.3389\/fphys.2020.594097","article-title":"The Role of Connexin 43 and Pannexin 1 during Acute Inflammation","volume":"11","author":"Kameritsch","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Garcia-Vega, L., O\u2019Shaughnessy, E.M., Albuloushi, A., and Martin, P.E. (2021). Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26. Biology, 10.","DOI":"10.3390\/biology10010059"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbamem.2012.01.002","article-title":"The participation of plasma membrane hemichannels to purinergic signaling","volume":"1828","author":"Pelegrin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Garcia-Vega, L., O\u2019Shaughnessy, E.M., Jan, A., Bartholomew, C., and Martin, P.E. (2019). Connexin 26 and 43 play a role in regulating proinflammatory events in the epidermis. J. Cell. Physiol.","DOI":"10.1002\/jcp.28206"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI27186","article-title":"Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response","volume":"116","author":"Djalilian","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"606","DOI":"10.33594\/000000160","article-title":"Stimulation of the A2B Adenosine Receptor Subtype Enhances Connexin26 Hemichannel Activity in Small Airway Epithelial Cells","volume":"53","author":"Dierks","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"O\u2019Shaughnessy, E.M., Duffy, W., Garcia-Vega, L., Hussey, K., Burden, A.D., Zamiri, M., and Martin, P.E. (2021). Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116060"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature14175","article-title":"Clinical improvement in psoriasis with specific targeting of interleukin-23","volume":"521","author":"Kopp","year":"2015","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4049\/jimmunol.1601549","article-title":"Critical Role of P2Y12 Receptor in Regulation of Th17 Differentiation and Experimental Autoimmune Encephalomyelitis Pathogenesis","volume":"199","author":"Qin","year":"2017","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2016.12.001","article-title":"Knockout of P2Y12 aggravates experimental autoimmune encephalomyelitis in mice via increasing of IL-23 production and Th17 cell differentiation by dendritic cells","volume":"62","author":"Zhang","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","article-title":"Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases","volume":"13","author":"Cronstein","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2174\/1381612825666190716145206","article-title":"Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis","volume":"25","author":"Shakya","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/exd.12461","article-title":"Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice","volume":"23","author":"Arasa","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neuroscience.2016.05.028","article-title":"Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels","volume":"330","author":"Liu","year":"2016","journal-title":"Neuroscience"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/art.40554","article-title":"The Antifibrotic Effect of A2B Adenosine Receptor Antagonism in a Mouse Model of Dermal Fibrosis","volume":"70","author":"Molina","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_112","first-page":"20","article-title":"Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: Involvement of nuclear factor-kappaB in mediating receptor level","volume":"34","author":"Madi","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cellimm.2009.03.020","article-title":"The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn\u2019s disease","volume":"258","author":"Ochaion","year":"2009","journal-title":"Cell. Immunol."},{"key":"ref_114","first-page":"931","article-title":"Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II\/III Multicenter, Randomized, Controlled Trial","volume":"15","author":"David","year":"2016","journal-title":"J. Drugs Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/ar2078","article-title":"Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression","volume":"8","author":"Ochaion","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdermsci.2021.06.001","article-title":"Mechanical stretch-induced ATP release from keratinocytes triggers Koebner phenomenon in psoriasis","volume":"103","author":"Okamoto","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.4049\/jimmunol.1202045","article-title":"Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: Implications in the pathogenesis of psoriasis","volume":"190","author":"Killeen","year":"2013","journal-title":"J. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","article-title":"P2X receptors as cell-surface ATP sensors in health and disease","volume":"442","author":"Khakh","year":"2006","journal-title":"Nature"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"694831","DOI":"10.3389\/fcell.2021.694831","article-title":"The P2X7 Receptor in Tumor Immunity","volume":"9","author":"Grassi","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ibd.20410","article-title":"Therapeutic benefit of pentostatin in severe IL-10\u2212\/\u2212 colitis","volume":"14","author":"Brown","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13555-017-0216-z","article-title":"Durable Resolution of Severe Psoriasis in a Patient Treated with Pentostatin for Hairy Cell Leukemia: A Case Report","volume":"8","author":"Alsuliman","year":"2018","journal-title":"Dermatol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/pr.117.014878","article-title":"The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases","volume":"71","author":"Antonioli","year":"2019","journal-title":"Pharmacol. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:53:17Z","timestamp":1760165597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":122,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22179449"],"URL":"https:\/\/doi.org\/10.3390\/ijms22179449","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}